---
document_datetime: 2024-12-05 13:12:52
document_pages: 9
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/ovaleap-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: ovaleap-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 6.3117168
conversion_datetime: 2025-12-28 04:34:59.118118
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Ovaleap

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0041              | B.II.g.5.c - Implementation of changes foreseen in an approved change management protocol - For a biological/immunological medicinal product | 02/12/2024                          |                                             | Annex II and PL                  |           |
| IA/0040              | A.7 - Administrative change - Deletion of manufacturing sites                                                                                | 19/07/2024                          |                                             | Annex II and PL                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| II/0039            | B.II.g.2 - Introduction of a post approval change management protocol related to the finished product                                                                                                                                                                                                                                                                                                                                                  | 27/06/2024   | n/a        |             |                                   |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|-----------------------------------|
| IB/0038            | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                           | 25/07/2023   | 16/08/2023 | SmPC and PL |                                   |
| IB/0037/G          | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting | 27/02/2023   | n/a        |             |                                   |
| PSUSA/1463/ 202110 | Periodic Safety Update EU Single assessment - follitropin alfa                                                                                                                                                                                                                                                                                                                                                                                         | 10/06/2022   | n/a        |             | PRAC Recommendation - maintenance |
| IB/0035/G          | This was an application for a group of variations. B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging -                                                                                                                                                                                                                                        | 18/08/2021   | n/a        |             |                                   |

<div style=\"page-break-after: always\"></div>

|         | A.7 - Administrative change - Deletion of manufacturing sites B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.I.a.1.k - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - New storage site of MCB and/or WCB   |            |     | Device with CE marking   |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------------|
| II/0034 | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 06/05/2021 | n/a |                          |
| IB/0033 | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 04/06/2020 | n/a |                          |
| II/0032 | B.II.e.1.a.3 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Sterile medicinal products and biological/immunological medicinal products                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 12/03/2020 | n/a |                          |
| IB/0031 | B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS -                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 11/11/2019 | n/a |                          |

<div style=\"page-break-after: always\"></div>

|                    | Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place                                                                                                  |            |            |                        |                                   |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| IAIN/0030          | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                     | 30/08/2019 | n/a        |                        |                                   |
| IB/0029            | B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol                                                    | 28/06/2019 | 18/06/2020 | SmPC                   |                                   |
| PSUSA/1463/ 201810 | Periodic Safety Update EU Single assessment - follitropin alfa                                                                                                                                                                         | 14/06/2019 | n/a        |                        | PRAC Recommendation - maintenance |
| T/0027             | Transfer of Marketing Authorisation                                                                                                                                                                                                    | 04/12/2018 | 11/01/2019 | SmPC, Labelling and PL |                                   |
| N/0026             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                       | 26/10/2018 | 11/01/2019 | PL                     |                                   |
| IAIN/0025          | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 27/07/2018 | 11/01/2019 | Annex II and PL        |                                   |
| IB/0024            | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch                                                                                         | 12/06/2018 | n/a        |                        |                                   |

<div style=\"page-break-after: always\"></div>

|             | control/testing takes place                                                                                                                                                                                                                                  |            |            |                        |         |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|---------|
| R/0023      | Renewal of the marketing authorisation.                                                                                                                                                                                                                      | 22/03/2018 | 16/05/2018 | SmPC, Labelling and PL |         |
| IB/0022     | B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits                                                                                                                               | 18/11/2017 | n/a        |                        |         |
|             | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 11/08/2017 | 16/05/2018 | SmPC, Annex II and PL  | IB/0021 |
| IB/0020     | B.I.a.1.k - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - New storage site of MCB and/or WCB                                                                                                                      | 20/07/2017 | n/a        |                        |         |
| IA/0019     | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                | 14/07/2017 | 16/05/2018 | Annex II and PL        |         |
| IB/0018     | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                   | 16/02/2017 | n/a        |                        |         |
| IAIN/0017/G | This was an application for a group of variations.                                                                                                                                                                                                           | 08/07/2016 | 12/04/2017 | Annex II and PL        |         |

<div style=\"page-break-after: always\"></div>

|                    | and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release             |            |            |                 |                                   |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-----------------------------------|
| PSUSA/1463/ 201510 | Periodic Safety Update EU Single assessment - follitropin alfa                                                                                                                                                                                                                                                                     | 09/06/2016 | n/a        |                 | PRAC Recommendation - maintenance |
| IB/0016            | B.I.c.1.a - Change in immediate packaging of the AS - Qualitative and/or quantitative composition                                                                                                                                                                                                                                  | 27/05/2016 | n/a        |                 |                                   |
| IB/0015            | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                      | 24/05/2016 | n/a        |                 |                                   |
| IAIN/0014          | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                             | 23/03/2016 | 12/04/2017 | Annex II and PL |                                   |
| IB/0013/G          | This was an application for a group of variations. B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.I.d.1.c - Stability of AS - Change in the re-test period/storage period or storage conditions - Change | 22/03/2016 | n/a        |                 |                                   |

<div style=\"page-break-after: always\"></div>

|           | to an approved stability protocol                                                                                                                                                                                                                                                                                                                                                                         |            |     |                          |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------------|
| IB/0011   | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                | 22/01/2016 | n/a |                          |
| IAIN/0010 | B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking                                                                                                                                                                                                                       | 07/01/2016 | n/a |                          |
| IA/0009   | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                                                                              | 12/08/2015 | n/a |                          |
| IA/0008/G | This was an application for a group of variations. B.II.c.1.c - Change in the specification parameters and/or limits of an excipient - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect information | 27/03/2015 | n/a | the product              |
| II/0006/G | This was an application for a group of variations. or addition of a                                                                                                                                                                                                                                                                                                                                       | 26/02/2015 | n/a | B.II.b.1.c - Replacement |

<div style=\"page-break-after: always\"></div>

|             | for the FP - Site where any manufacturing operation(s) take place, except batch release/control, and secondary packaging, for biol/immunol medicinal products or pharmaceutical forms manufactured by complex manufacturing processes B.II.b.4.c - Change in the batch size (including batch size ranges) of the finished product - The change requires assessment of the comparability of a biological/immunological medicinal product or a new bioequivalence study   |            |            |                        | manufacturing site   |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------|
| IB/0007     | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                                                                     | 10/02/2015 | n/a        |                        |                      |
| IB/0004     | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                                                            | 27/10/2014 | n/a        |                        |                      |
| T/0005      | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                     | 29/08/2014 | 16/09/2014 | SmPC, Labelling and PL |                      |
| IA/0002     | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                     | 30/07/2014 | n/a        |                        |                      |
| IAIN/0003/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                      | 24/07/2014 | n/a        |                        |                      |

<div style=\"page-break-after: always\"></div>

|         | A.7 - Administrative change - Deletion of manufacturing sites B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site   |            |            |             |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|
| IB/0001 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                     | 12/05/2014 | 16/09/2014 | SmPC and PL |